PGN-EDODM1 clinical trials

A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1

This study is looking at a new medicine called PGN-EDODM1 for Myotonic Dystrophy Type 1 (DM1). Researchers want to see how safe it is and how well people tolerate it compared to a dummy medicine (placebo). It's for adults aged 16 to 65.